Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Patient Access Solutions Companies and Leadership Alignment with their Offerings

Date : 09 December 2025

Patient Access Solutions Market Companies with Value Chanin Analysis

Patient Access Solutions Market Key Players

Market Growth

The global patient access solutions market size is calculated at US$ 2.46 billion in 2025, grew to US$ 2.68 billion in 2026, and is projected to reach around US$ 5.78 billion by 2035. The market is expanding at a CAGR of 8.94% between 2026 and 2035.

Patient Access Solutions Market Trends and Growth (2026)

Top Vendors in the Patient Access Solutions Market & Their Offerings

Vendor Key patient-access offerings (concise)
Epic Systems Integrated access & revenue-cycle suite: appointment scheduling, patient registration & self-service (MyChart), referrals/authorizations, front-end eligibility checks, and integration with Epic RCM.
Oracle Health (Cerner) Patient administration & revenue-cycle platform: self-service scheduling/registration, EHR integration, eligibility verification, cloud-hosted revenue and claims workflow automation.
McKesson End-to-end provider solutions including specialty patient access (CoverMyMeds/AMP), medication access/affordability services, practice management integration, and pharmacy-centric access support.
Veradigm (formerly Allscripts) EHR + practice management + patient engagement modules: registration, patient portals, scheduling, API/connectivity for third-party access tools, and practice workflow customization.
athenahealth Cloud-native patient engagement & practice management: digital portals, appointment management, intake/registration, patient communication, and integrated billing/RCM services
Waystar Cloud RCM + patient financial experience platform: eligibility & benefits verification, payment & estimate tools, claims/denials management, and automation to improve patient collections.
Phreesia Patient intake & access platform: digital check-in/registration, forms, insurance capture, payments at point-of-service, specialty intake templates, and EHR integrations
Kyruus Health Care-access platform focused on provider-search & patient-provider matching, scheduling/visibility, provider data management, and enabling search → schedule → start patient journeys.
R1 RCM End-to-end revenue cycle & patient access services: blended self-service intake, insurance verification, patient payment/collections tools, denial prevention, and AI/automation-enabled workflows.
Optum / Optum360 Large-scale patient access & engagement services: contact-center scheduling, digital access, patient clearance/financial clearance, coding/claims support (Optum360), and analytics-driven operations.

Patient Access Solutions Market Value Chain Analysis

  • Research & Development: Companies identify disease targets, discover candidate drugs or biologics, perform preclinical studies, and develop formulations for clinical use.
  • Key Players: Pfizer, Novartis, Roche, Merck, WuXi AppTec, Charles River Laboratories, IQVIA
  • Clinical Trials & Regulatory Approval: Organizations design and run Phase 1–3 trials, monitor patient safety and data, and submit regulatory filings to gain approval.
  • Key Players: IQVIA, Parexel, ICON, PPD/Labcorp, FDA, EMA, MHRA, PMDA
  • Patient Support & Services: Providers assess patient eligibility, handle prior authorizations and reimbursement, and deliver specialty dispensing and adherence support.
  • Key Players: CVS Specialty, Accredo, Walgreens Specialty Pharmacy, Optum Specialty, TrialCard, CoverMyMeds, McKesson Specialty Health

Recent Developments in the Patient Access Solutions Market

  • In December 2025, Accord Healthcare announced the launch of a biosimilar to Prolia (Amgen), Osvyrti (denosumab), and Jubereq (denosumab), a biosimilar to Xgeva (Amgen), following the patent expiration of the reference medicine on November 27, 2025.
  • In November 2025, Datavant: Data Collaboration platform trusted for healthcare, announced a strategic partnership with United BioSource Corporation (UBC), a leading provider of real-world evidence, patient access, and comprehensive risk-management and safety solutions. This collaboration brings together Datavant's industry-leading data connectivity and privacy expertise with UBC's deep domain expertise in specialty therapies, empowering pharmaceutical leaders to make more meaningful and timely decisions in late-phase research and commercialization.

Collaborate with our experts to explore the Patient Access Solutions Market at sales@towardshealthcare.com

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales